What 720,000 adults reveal about artificial sweeteners and diabetes risk
Data from more than 720,000 adults suggest that long-term consumption of artificial sweeteners may not be metabolically neutral,…
Serena Williams Defends GLP-1 Weight-Loss Drug Use: What Doctors Want You To Know
Tennis legend Serena Williams is speaking openly about her decision to use a GLP-1 weight-loss medication, adding her…
Protein craze can lead to better health if done right
It’s a question that Dr. Travis Wilkes gets asked every day by patients. It is something that Dr.…
Approval of weight loss drug for sleep apnea could create financial risk for plan sponsors: expert
Canadian employers expanding GLP-1 coverage for weight loss: survey Nearly two-fifths (37 per cent) of Canadian employers cover…
Obesity in Guernsey needs ‘whole systems approach’
Obesity in Guernsey needs a “whole systems approach,” a report into the issue has said. Figures for last…
Most ‘GLP-1 Nonresponders’ Never Get a Fair Shot
I see this pattern every week. A patient is 12 weeks into semaglutide therapy. They’ve lost 2%-3% of…
What to know about Medicare’s $50 GLP-1 program
NEW YORK (AP) — Popular — and expensive — GLP-1 weight loss drugs just got a lot cheaper…
The good, bad and ugly of GLP-1 weight-loss drugs: Ozempic scams, celebrity hype and nasty side effects
It seems like no matter where you go, from a family braai to office chatter, or even just…
Canada approves first generic semaglutide injection for weight loss
FILE – A dosage of Wegovy, March 1, 2024 in Front Royal, Va. (AP Photo/Amanda Andrade-Rhoades, File) –…
Regulators issue warning on ads for unlicensed weight loss drugs – Chemist+Druggist
Regulators issue warning on ads for unlicensed weight loss drugs Chemist+DruggistNovo Nordisk to seek regulatory approval for Wegovy pill…
Walking 6K, 12K or 18K steps a day? Fitness coach reveals how many pounds of fat you could lose
If you’re looking for a sustainable way to lose weight, the answer could be as simple as putting…
Forget Zepbound: Eli Lilly’s Next Billion-Dollar Weight-Loss Drug May Be Even Better
Eli Lilly (NYSE: LLY) has been posting incredible sales and earnings growth in recent quarters, thanks in no…